Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2789 | 2147 | 27.9 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
112 | 3 | CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY | 70812 |
185 | 2 | OVARIAN CANCER//GYNECOLOGIC ONCOLOGY//OVARIAN NEOPLASMS | 21857 |
2789 | 1 | CA 125//HE4//CA125 | 2147 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CA 125 | authKW | 2328456 | 17% | 44% | 372 |
2 | HE4 | authKW | 1992450 | 7% | 87% | 161 |
3 | CA125 | authKW | 1590594 | 12% | 43% | 258 |
4 | HUMAN EPIDIDYMIS PROTEIN 4 | authKW | 614090 | 2% | 94% | 46 |
5 | OVARIAN CANCER | authKW | 242641 | 21% | 4% | 447 |
6 | CA 125 ANTIGEN | authKW | 209387 | 2% | 41% | 36 |
7 | RISK OF OVARIAN MALIGNANCY ALGORITHM | authKW | 156426 | 1% | 100% | 11 |
8 | MUC16 | authKW | 150613 | 1% | 42% | 25 |
9 | TUMOR MARKER | authKW | 135127 | 8% | 5% | 181 |
10 | CARBOHYDRATE ANTIGEN 125 | authKW | 134931 | 1% | 43% | 22 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Obstetrics & Gynecology | 41063 | 42% | 0% | 897 |
2 | Oncology | 18250 | 48% | 0% | 1025 |
3 | Reproductive Biology | 2164 | 7% | 0% | 140 |
4 | Medical Laboratory Technology | 1802 | 5% | 0% | 108 |
5 | Pathology | 247 | 4% | 0% | 80 |
6 | Medicine, General & Internal | 141 | 5% | 0% | 118 |
7 | Medicine, Research & Experimental | 129 | 4% | 0% | 88 |
8 | Biotechnology & Applied Microbiology | 15 | 3% | 0% | 59 |
9 | BIOLOGY, MISCELLANEOUS | 7 | 0% | 0% | 1 |
10 | Cardiac & Cardiovascular System | 3 | 2% | 0% | 41 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CNR IBPM | 49765 | 0% | 50% | 7 |
2 | BIOMARKERS EMERGING TECHNOL | 45504 | 0% | 80% | 4 |
3 | IMMUNOCHEM GLYCOBIOL | 44435 | 0% | 63% | 5 |
4 | GYNAECOL CANC UNIT | 36448 | 0% | 26% | 10 |
5 | OVARIAN CANC SCREENING UNIT | 28441 | 0% | 100% | 2 |
6 | STOLLER BIOMARKER DISCOVERY PATHOL NODE | 28441 | 0% | 100% | 2 |
7 | ZIMMER CANC | 28441 | 0% | 100% | 2 |
8 | GYNECOL SURG GYNECOL ONCOL ADULTS ADOLES | 25589 | 0% | 30% | 6 |
9 | GYNECOL ONCOL | 22703 | 6% | 1% | 134 |
10 | PROGRAM WOMENS ONCOL OBSTET GYNECOL | 21328 | 0% | 50% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GYNECOLOGIC ONCOLOGY | 62217 | 10% | 2% | 223 |
2 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 16948 | 3% | 2% | 73 |
3 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 13089 | 2% | 2% | 52 |
4 | JOURNAL OF OVARIAN RESEARCH | 10398 | 1% | 4% | 19 |
5 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 9849 | 1% | 3% | 25 |
6 | TUMOR BIOLOGY | 9103 | 3% | 1% | 63 |
7 | GYNECOLOGIC AND OBSTETRIC INVESTIGATION | 4685 | 2% | 1% | 35 |
8 | JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES | 4175 | 0% | 3% | 10 |
9 | EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 3564 | 1% | 1% | 27 |
10 | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 3374 | 3% | 0% | 70 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CA 125 | 2328456 | 17% | 44% | 372 | Search CA+125 | Search CA+125 |
2 | HE4 | 1992450 | 7% | 87% | 161 | Search HE4 | Search HE4 |
3 | CA125 | 1590594 | 12% | 43% | 258 | Search CA125 | Search CA125 |
4 | HUMAN EPIDIDYMIS PROTEIN 4 | 614090 | 2% | 94% | 46 | Search HUMAN+EPIDIDYMIS+PROTEIN+4 | Search HUMAN+EPIDIDYMIS+PROTEIN+4 |
5 | OVARIAN CANCER | 242641 | 21% | 4% | 447 | Search OVARIAN+CANCER | Search OVARIAN+CANCER |
6 | CA 125 ANTIGEN | 209387 | 2% | 41% | 36 | Search CA+125+ANTIGEN | Search CA+125+ANTIGEN |
7 | RISK OF OVARIAN MALIGNANCY ALGORITHM | 156426 | 1% | 100% | 11 | Search RISK+OF+OVARIAN+MALIGNANCY+ALGORITHM | Search RISK+OF+OVARIAN+MALIGNANCY+ALGORITHM |
8 | MUC16 | 150613 | 1% | 42% | 25 | Search MUC16 | Search MUC16 |
9 | TUMOR MARKER | 135127 | 8% | 5% | 181 | Search TUMOR+MARKER | Search TUMOR+MARKER |
10 | CARBOHYDRATE ANTIGEN 125 | 134931 | 1% | 43% | 22 | Search CARBOHYDRATE+ANTIGEN+125 | Search CARBOHYDRATE+ANTIGEN+125 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHUDECKA-GLAZ, AM , (2015) ROMA, AN ALGORITHM FOR OVARIAN CANCER.CLINICA CHIMICA ACTA. VOL. 440. ISSUE . P. 143 -151 | 81 | 81% | 10 |
2 | TUXEN, MK , (2001) TUMOR MARKER CA125 IN OVARIAN CANCER.JOURNAL OF TUMOR MARKER ONCOLOGY. VOL. 16. ISSUE 1. P. 49-68 | 101 | 81% | 7 |
3 | SIMMONS, AR , BAGGERLY, K , BAST, RC , (2013) THE EMERGING ROLE OF HE4 IN THE EVALUATION OF EPITHELIAL OVARIAN AND ENDOMETRIAL CARCINOMAS.ONCOLOGY-NEW YORK. VOL. 27. ISSUE 6. P. 548 -556 | 58 | 91% | 11 |
4 | SIKARIS, KA , (2011) CA125-A TEST WITH A CHANGE OF HEART.HEART LUNG AND CIRCULATION. VOL. 20. ISSUE 10. P. 634-640 | 65 | 86% | 8 |
5 | VANDERBURG, MEL , LAMMES, FB , VERWEIJ, J , (1992) CA-125 IN OVARIAN-CANCER.NETHERLANDS JOURNAL OF MEDICINE. VOL. 40. ISSUE 1-2. P. 36-51 | 123 | 82% | 29 |
6 | COLLOCA, G , VENTURINO, A , GOVERNATO, I , (2016) CA125-RELATED TUMOR CELL KINETICS VARIABLES AFTER CHEMOTHERAPY IN ADVANCED OVARIAN CANCER: A SYSTEMATIC REVIEW.CLINICAL & TRANSLATIONAL ONCOLOGY. VOL. 18. ISSUE 8. P. 813 -824 | 64 | 79% | 0 |
7 | QU, WL , LI, JP , DUAN, P , TANG, ZQ , GUO, FB , CHEN, HB , ZHU, XQ , JIANG, SW , (2016) PHYSIOPATHOLOGICAL FACTORS AFFECTING THE DIAGNOSTIC VALUE OF SERUM HE4-TEST FOR GYNECOLOGIC MALIGNANCIES.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 16. ISSUE 12. P. 1271 -1282 | 66 | 75% | 0 |
8 | JIA, LT , ZHANG, YC , LI, J , TIAN, Y , LI, JF , (2016) THE ROLE OF HUMAN EPIDIDYMIS PROTEIN 4 IN THE DIAGNOSIS OF EPITHELIAL OVARIAN CANCER.CLINICAL & TRANSLATIONAL ONCOLOGY. VOL. 18. ISSUE 3. P. 233 -239 | 49 | 86% | 2 |
9 | GUPTA, D , LIS, CG , (2009) ROLE OF CA125 IN PREDICTING OVARIAN CANCER SURVIVAL - A REVIEW OF THE EPIDEMIOLOGICAL LITERATURE.JOURNAL OF OVARIAN RESEARCH. VOL. 2. ISSUE 1. P. - | 60 | 85% | 46 |
10 | SOLETORMOS, G , DUFFY, MJ , ABU HASSAN, SO , VERHEIJEN, RHM , THOLANDER, B , BAST, RC , GAARENSTROOM, KN , STURGEON, CM , BONFRER, JM , PETERSEN, PH , ET AL (2016) CLINICAL USE OF CANCER BIOMARKERS IN EPITHELIAL OVARIAN CANCER UPDATED GUIDELINES FROM THE EUROPEAN GROUP ON TUMOR MARKERS.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 26. ISSUE 1. P. 43 -51 | 42 | 66% | 11 |
Classes with closest relation at Level 1 |